Slide Insurance Holdings, Inc.·4

Mar 25, 4:29 PM ET

LARSON MATTHEW PAUL 4

4 · Slide Insurance Holdings, Inc. · Filed Mar 25, 2026

Research Summary

AI-generated summary of this filing

Updated

Slide Insurance (SLDE) CRO Matthew Larson Exercises Options, Sells Shares

What Happened
Matthew Paul Larson, Chief Risk Officer of Slide Insurance Holdings (SLDE), exercised stock options and immediately sold the resulting shares on March 24, 2026. He exercised 11,250 options at a $0.79 strike (cost $8,888) and sold 11,250 shares in an open-market transaction at $18.00 per share for total gross proceeds of $202,500 (approximately $193,612 net of the exercise cost, before fees and taxes). The filing shows the exercise/conversion of the related derivative instrument as well.

Key Details

  • Transaction date: 2026-03-24 (Form 4 filed 2026-03-25).
  • Exercise: 11,250 options exercised at $0.79 = $8,888 total (report shows options fully vested and exercisable).
  • Sale: 11,250 shares sold at $18.00 = $202,500 total.
  • Additional derivative entry: 11,250 shares reported as converted/disposed at $0.00 (reflects the option-to-share conversion).
  • Footnotes: F1 — the exercise and sale were executed pursuant to a 10b5-1 trading plan adopted Dec 4, 2025. F2 — those stock options were fully vested and exercisable.
  • Shares owned after the transaction: not specified in the provided excerpt of the filing.
  • Timeliness: filed the next day (appears timely; no late-filing indication).

Context
This was an option exercise followed by an immediate sale (common "exercise-and-sell" or cashless-style event) executed under a pre-established 10b5-1 plan, which is a routine mechanism insiders use to sell shares without trading on nonpublic information. Sales are not by themselves a clear signal of company outlook; purchases often provide stronger directional signals. The filing code M indicates option exercise and S indicates a sale; the derivative entry documents the conversion/settlement of the option.

Insider Transaction Report

Form 4
Period: 2026-03-24
LARSON MATTHEW PAUL
Chief Risk Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-24$0.79/sh+11,250$8,88811,250 total
  • Sale

    Common Stock

    [F1]
    2026-03-24$18.00/sh11,250$202,5000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F2]
    2026-03-2411,25053,750 total
    Exercise: $0.79Exp: 2032-02-21Common Stock (11,250 underlying)
Footnotes (2)
  • [F1]Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.
  • [F2]These stock options are fully vested and exercisable.
Signature
/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson|2026-03-25

Documents

1 file
  • 4
    ownership.xmlPrimary

    4